{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T03:13:26Z","timestamp":1790651606333,"version":"4.1.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2022,7,16]],"date-time":"2022-07-16T00:00:00Z","timestamp":1657929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,7,16]],"date-time":"2022-07-16T00:00:00Z","timestamp":1657929600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["CP17\/0018"],"award-info":[{"award-number":["CP17\/0018"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL1TR001881"],"award-info":[{"award-number":["UL1TR001881"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1245\/s10434-022-12143-6","type":"journal-article","created":{"date-parts":[[2022,7,16]],"date-time":"2022-07-16T17:02:44Z","timestamp":1657990964000},"page":"6407-6414","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Machine Learning-Based Epigenetic Classifiers for Axillary Staging of Patients with ER-Positive Early-Stage Breast Cancer"],"prefix":"10.1245","volume":"29","author":[{"given":"Javier I. J.","family":"Orozco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Le","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miquel","family":"Ensenyat-Mendez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer L.","family":"Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne","family":"Weidhaas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Klomhaus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego M.","family":"Marzese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1926-292X","authenticated-orcid":false,"given":"Maggie L.","family":"DiNome","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,16]]},"reference":[{"key":"12143_CR1","unstructured":"Society of Surgical Oncology. Choosing Wisely: Don\u2019t routinely use sentinel node biopsy in clinically node negative women \u2265 70 years of age with early stage hormone receptor positive, HER2 negative invasive breast cancer. https:\/\/www.choosingwisely.org\/clinician-lists\/sso-sentinel-node-biopsy-in-node-negative-women-70-and-over\/. Updated 07\/27\/2021. Accessed 8 March 2022."},{"key":"12143_CR2","unstructured":"National Comprehensive Cancer Network. Breast Cancer (Version 3.2022). https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/breast.pdf. Accessed 18 May 2022."},{"issue":"10","key":"12143_CR3","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1001\/jama.2017.11470","volume":"318","author":"AE Giuliano","year":"2017","unstructured":"Giuliano AE, Ballman KV, McCall L, et al. Effect of axillary dissection vs no axillary dissection on 10-year overall survival among women with invasive breast cancer and sentinel node metastasis: the ACOSOG Z0011 (Alliance) randomized clinical trial. JAMA. 2017;318(10):918\u201326.","journal-title":"JAMA."},{"issue":"25","key":"12143_CR4","doi-asserted-by":"publisher","first-page":"2336","DOI":"10.1056\/NEJMoa2108873","volume":"385","author":"K Kalinsky","year":"2021","unstructured":"Kalinsky K, Barlow WE, Gralow JR, et al. 21-gene assay to inform chemotherapy benefit in node-positive breast cancer. N Engl J Med. 2021;385(25):2336\u201347.","journal-title":"N Engl J Med."},{"issue":"6","key":"12143_CR5","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1056\/NEJMoa012782","volume":"349","author":"U Veronesi","year":"2003","unstructured":"Veronesi U, Paganelli G, Viale G, et al. A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med. 2003;349(6):546\u201353.","journal-title":"N Engl J Med."},{"issue":"10","key":"12143_CR6","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/S1470-2045(10)70207-2","volume":"11","author":"DN Krag","year":"2010","unstructured":"Krag DN, Anderson SJ, Julian TB, et al. Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial. Lancet Oncol. 2010;11(10):927\u201333.","journal-title":"Lancet Oncol."},{"issue":"24","key":"12143_CR7","doi-asserted-by":"publisher","first-page":"3670","DOI":"10.1200\/JCO.2006.08.8013","volume":"25","author":"JL Bevilacqua","year":"2007","unstructured":"Bevilacqua JL, Kattan MW, Fey JV, Cody HS 3rd, Borgen PI, Van Zee KJ. Doctor, what are my chances of having a positive sentinel node? A validated nomogram for risk estimation. J Clin Oncol. 2007;25(24):3670\u20139.","journal-title":"J Clin Oncol."},{"issue":"5","key":"12143_CR8","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1245\/s10434-009-0399-3","volume":"16","author":"M Klar","year":"2009","unstructured":"Klar M, Foeldi M, Markert S, Gitsch G, Stickeler E, Watermann D. Good prediction of the likelihood for sentinel lymph node metastasis by using the MSKCC nomogram in a German breast cancer population. Ann Surg Oncol. 2009;16(5):1136\u201342.","journal-title":"Ann Surg Oncol."},{"issue":"3","key":"12143_CR9","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1007\/s10549-012-2219-x","volume":"135","author":"JY Chen","year":"2012","unstructured":"Chen JY, Chen JJ, Yang BL, et al. Predicting sentinel lymph node metastasis in a Chinese breast cancer population: assessment of an existing nomogram and a new predictive nomogram. Breast Cancer Res Treat. 2012;135(3):839\u201348.","journal-title":"Breast Cancer Res Treat."},{"issue":"5","key":"12143_CR10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0020297","volume":"6","author":"F Reyal","year":"2011","unstructured":"Reyal F, Rouzier R, Depont-Hazelzet B, et al. The molecular subtype classification is a determinant of sentinel node positivity in early breast carcinoma. PLoS One. 2011;6(5):e20297.","journal-title":"PLoS One."},{"issue":"1","key":"12143_CR11","doi-asserted-by":"publisher","first-page":"4627","DOI":"10.1038\/s41467-018-06715-y","volume":"9","author":"JIJ Orozco","year":"2018","unstructured":"Orozco JIJ, Knijnenburg TA, Manughian-Peter AO, et al. Epigenetic profiling for the molecular classification of metastatic brain tumors. Nat Commun. 2018;9(1):4627.","journal-title":"Nat Commun."},{"issue":"10","key":"12143_CR12","doi-asserted-by":"publisher","first-page":"3344","DOI":"10.1245\/s10434-019-07565-8","volume":"26","author":"ML DiNome","year":"2019","unstructured":"DiNome ML, Orozco JIJ, Matsuba C, et al. Clinicopathological features of triple-negative breast cancer epigenetic subtypes. Ann Surg Oncol. 2019;26(10):3344\u201353.","journal-title":"Ann Surg Oncol."},{"issue":"2","key":"12143_CR13","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s10585-015-9695-4","volume":"32","author":"G Urrutia","year":"2015","unstructured":"Urrutia G, Laurito S, Marzese DM, et al. Epigenetic variations in breast cancer progression to lymph node metastasis. Clin Exp Metastasis. 2015;32(2):99\u2013110.","journal-title":"Clin Exp Metastasis."},{"key":"12143_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/sdata.2018.245","volume":"5","author":"MP Salomon","year":"2018","unstructured":"Salomon MP, Orozco JIJ, Wilmott JS, et al. Brain metastasis DNA methylomes, a novel resource for the identification of biological and clinical features. Sci Data. 2018;5:180245.","journal-title":"Sci Data."},{"key":"12143_CR15","unstructured":"National Cancer Institute\/GDC Data Portal. Harmonized Cancer Datasets. Genomic Data Commons Data Portal. https:\/\/portal.gdc.cancer.gov. Accessed 1 August 2020."},{"key":"12143_CR16","unstructured":"Memorial Sloan Kettering Cancer Center. Breast cancer nomogram: sentinel lymph node metastasis. http:\/\/nomograms.mskcc.org\/breast\/BreastSLNodeMetastasisPage.aspx. Accessed 9 November 2020."},{"key":"12143_CR17","unstructured":"MD Anderson Cancer Center. Breast cancer nomogram to predict positive sentinel lymph nodes, without neoadjuvant chemotherapy. http:\/\/www3.mdanderson.org\/app\/medcalc\/bc_nomogram3\/index.cfm?pagename=sln. Accessed 9 November 2020."},{"issue":"8","key":"12143_CR18","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkv1507","volume":"44","author":"A Colaprico","year":"2016","unstructured":"Colaprico A, Silva TC, Olsen C, et al. TCGAbiolinks: an R\/Bioconductor package for integrative analysis of TCGA data. Nucleic Acids Res. 2016;44(8):e71.","journal-title":"Nucleic Acids Res."},{"key":"12143_CR19","doi-asserted-by":"publisher","first-page":"8971","DOI":"10.1038\/ncomms9971","volume":"6","author":"D Aran","year":"2015","unstructured":"Aran D, Sirota M, Butte AJ. Systematic pan-cancer analysis of tumour purity. Nat Commun. 2015;6:8971.","journal-title":"Nat Commun."},{"issue":"1","key":"12143_CR20","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1038\/s41598-020-58766-1","volume":"10","author":"CR John","year":"2020","unstructured":"John CR, Watson D, Russ D, et al. M3C: monte carlo reference-based consensus clustering. Sci Rep. 2020;10(1):1816.","journal-title":"Sci Rep."},{"issue":"12","key":"12143_CR21","doi-asserted-by":"publisher","first-page":"3902","DOI":"10.1093\/bioinformatics\/btaa227","volume":"36","author":"T O'Connor","year":"2020","unstructured":"O\u2019Connor T, Grant CE, Bod\u00e9n M, Bailey TL. T-gene: improved target gene prediction. Bioinformatics. 2020;36(12):3902\u20134.","journal-title":"Bioinformatics."},{"key":"12143_CR22","unstructured":"Grote S. GOfuncR: Gene ontology enrichment using FUNC. R package version 1.16.0. 2022."},{"key":"12143_CR23","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1186\/1471-2105-8-328","volume":"8","author":"R Diaz-Uriarte","year":"2007","unstructured":"Diaz-Uriarte R. GeneSrF and varSelRF: a web-based tool and R package for gene selection and classification using random forest. BMC Bioinform. 2007;8:328.","journal-title":"BMC Bioinform"},{"issue":"20","key":"12143_CR24","doi-asserted-by":"publisher","first-page":"3940","DOI":"10.1093\/bioinformatics\/bti623","volume":"21","author":"T Sing","year":"2005","unstructured":"Sing T, Sander O, Beerenwinkel N, Lengauer T. ROCR: visualizing classifier performance in R. Bioinformatics. 2005;21(20):3940\u20131.","journal-title":"Bioinformatics"},{"issue":"3","key":"12143_CR25","doi-asserted-by":"publisher","first-page":"837","DOI":"10.2307\/2531595","volume":"44","author":"ER DeLong","year":"1988","unstructured":"DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988;44(3):837\u201345.","journal-title":"Biometrics"},{"issue":"6","key":"12143_CR26","doi-asserted-by":"publisher","first-page":"438","DOI":"10.3322\/caac.21583","volume":"69","author":"CE DeSantis","year":"2019","unstructured":"DeSantis CE, Ma J, Gaudet MM, et al. Breast cancer statistics. CA Cancer J Clin. 2019;69(6):438\u201351.","journal-title":"CA Cancer J Clin."},{"issue":"12","key":"12143_CR27","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1016\/S1470-2045(14)70460-7","volume":"15","author":"M Donker","year":"2014","unstructured":"Donker M, van Tienhoven G, Straver ME, et al. Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981\u201322023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial. Lancet Oncol. 2014;15(12):1303\u201310.","journal-title":"Lancet Oncol."},{"issue":"11","key":"12143_CR28","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1093\/jjco\/hys150","volume":"42","author":"PF Qiu","year":"2012","unstructured":"Qiu PF, Liu JJ, Wang YS, et al. Risk factors for sentinel lymph node metastasis and validation study of the MSKCC nomogram in breast cancer patients. Jpn J Clin Oncol. 2012;42(11):1002\u20137.","journal-title":"Jpn J Clin Oncol."},{"issue":"10","key":"12143_CR29","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1016\/S1470-2045(16)30297-2","volume":"17","author":"S Moran","year":"2016","unstructured":"Moran S, Mart\u00ednez-Card\u00fas A, Sayols S, et al. Epigenetic profiling to classify cancer of unknown primary: a multicentre, retrospective analysis. Lancet Oncol. 2016;17(10):1386\u201395.","journal-title":"Lancet Oncol."},{"issue":"7697","key":"12143_CR30","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/nature26000","volume":"555","author":"D Capper","year":"2018","unstructured":"Capper D, Jones DTW, Sill M, et al. DNA methylation-based classification of central nervous system tumours. Nature. 2018;555(7697):469\u201374.","journal-title":"Nature"},{"issue":"10","key":"12143_CR31","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1038\/s41591-018-0156-x","volume":"24","author":"J Klughammer","year":"2018","unstructured":"Klughammer J, Kiesel B, Roetzer T, et al. The DNA methylation landscape of glioblastoma disease progression shows extensive heterogeneity in time and space. Nat Med. 2018;24(10):1611\u201324.","journal-title":"Nat Med."},{"issue":"8","key":"12143_CR32","doi-asserted-by":"publisher","first-page":"3090","DOI":"10.1172\/JCI91095","volume":"127","author":"J Jeschke","year":"2017","unstructured":"Jeschke J, Bizet M, Desmedt C, et al. DNA methylation-based immune response signature improves patient diagnosis in multiple cancers. J Clin Invest. 2017;127(8):3090\u2013102.","journal-title":"J Clin Invest."},{"issue":"1","key":"12143_CR33","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s13040-021-00273-8","volume":"14","author":"M Ensenyat-Mendez","year":"2021","unstructured":"Ensenyat-Mendez M, \u00cd\u00f1iguez-Mu\u00f1oz S, Ses\u00e9 B, Marzese DM. iGlioSub: an integrative transcriptomic and epigenomic classifier for glioblastoma molecular subtypes. BioData Min. 2021;14(1):42.","journal-title":"BioData Min."},{"issue":"7788","key":"12143_CR34","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/s41586-019-1799-6","volume":"577","author":"SM McKinney","year":"2020","unstructured":"McKinney SM, Sieniek M, Godbole V, et al. International evaluation of an AI system for breast cancer screening. Nature. 2020;577(7788):89\u201394.","journal-title":"Nature"},{"key":"12143_CR35","doi-asserted-by":"publisher","first-page":"40636","DOI":"10.1038\/srep40636","volume":"7","author":"M M\u00f8ller","year":"2017","unstructured":"M\u00f8ller M, Strand SH, Mundbjerg K, et al. Heterogeneous patterns of DNA methylation-based field effects in histologically normal prostate tissue from cancer patients. Sci Rep. 2017;7:40636.","journal-title":"Sci Rep."},{"issue":"1","key":"12143_CR36","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.jmoldx.2016.08.008","volume":"19","author":"B Uhl","year":"2017","unstructured":"Uhl B, Gevensleben H, Tolkach Y, et al. PITX2 DNA methylation as biomarker for individualized risk assessment of prostate cancer in core biopsies. J Mol Diagn. 2017;19(1):107\u201314.","journal-title":"J Mol Diagn."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-022-12143-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-022-12143-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-022-12143-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,9]],"date-time":"2022-09-09T19:58:44Z","timestamp":1662753524000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-022-12143-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,16]]},"references-count":36,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["12143"],"URL":"https:\/\/doi.org\/10.1245\/s10434-022-12143-6","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,16]]},"assertion":[{"value":"31 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have no conflict of interest disclosures to report.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}